Ototoxicity Clinical Trials in San Francisco, California
2 recruitingSan Francisco, California
Showing 1–2 of 2 trials
Recruiting
Phase 2
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Ototoxicity, Drug-Induced
Kevin Winthrop105 enrolled7 locationsNCT05730283
Recruiting
Phase 2
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
NephrotoxicityMucositisOtotoxicity
Matrix Biomed, Inc.120 enrolled9 locationsNCT03480971